
Janus Henderson Global Life Sciences Fund
JNGLX
Updated: 22/09/2026, 22:08:51
This fund aims to achieve its investment objective by typically allocating a minimum of 80% of its net assets (plus any capital borrowed for investment purposes) to companies that the portfolio manager believes exhibit a life science orientation. As a fundamental principle guiding its pursuit of life science-focused companies, the fund also has a policy to normally invest at least 25% of its total holdings in businesses formally classified within the "life sciences" sector.
No summaries found.
- Share price
- $88.60
- Market cap
- $5.87B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 04/01/1999
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $88.60 – $88.60
- 52-week range
- $68.78 – $94.22
- 1-day performance
- 0.43%
- 1-year performance
- 28.82%
- Current drawdown (1Y)
- -5.96%
- CIK
- 0000277751
- CUSIP
- 47103E700
- ISIN
- US47103E7004
- Created
- 07/12/2025, 04:53:05
- Last update
- 22/09/2026, 22:08:51
Track Janus Henderson Global Life Sciences Fund with an AI analyst
See which prediction-market events move JNGLX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.